Literature DB >> 25477611

Amitriptyline: interstitial cystitis (painful bladder syndrome).

Joyce A Generali1, Dennis J Cada2.   

Abstract

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@ku.edu.

Entities:  

Year:  2014        PMID: 25477611      PMCID: PMC4252183          DOI: 10.1310/hpj4909-809

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  7 in total

Review 1.  Interstitial cystitis: diagnosis and management.

Authors:  Monika Vij; Sushma Srikrishna; Linda Cardozo
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2012-02-04       Impact factor: 2.435

Review 2.  Interstitial cystitis/bladder pain syndrome: management of the pain disorder: a urogynecology perspective.

Authors:  Charles W Butrick
Journal:  Urol Clin North Am       Date:  2012-08       Impact factor: 2.241

3.  Long-term results of amitriptyline treatment for interstitial cystitis.

Authors:  Arndt van Ophoven; Lothar Hertle
Journal:  J Urol       Date:  2005-11       Impact factor: 7.450

4.  Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome.

Authors:  Harris E Foster; Philip M Hanno; J Curtis Nickel; Christopher K Payne; Robert D Mayer; David A Burks; Claire C Yang; Toby C Chai; Karl J Kreder; Kenneth M Peters; Emily S Lukacz; Mary P FitzGerald; Liyi Cen; J Richard Landis; Kathleen J Propert; Wei Yang; John W Kusek; Leroy M Nyberg
Journal:  J Urol       Date:  2010-03-29       Impact factor: 7.450

5.  A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis.

Authors:  Arndt van Ophoven; Sasa Pokupic; Achim Heinecke; Lothar Hertle
Journal:  J Urol       Date:  2004-08       Impact factor: 7.450

Review 6.  Treatment of bladder pain syndrome/interstitial cystitis 2008: can we make evidence-based decisions?

Authors:  Magnus Fall; Frank Oberpenning; Ralph Peeker
Journal:  Eur Urol       Date:  2008-04-03       Impact factor: 20.096

Review 7.  AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome.

Authors:  Philip M Hanno; David Allen Burks; J Quentin Clemens; Roger R Dmochowski; Deborah Erickson; Mary Pat Fitzgerald; John B Forrest; Barbara Gordon; Mikel Gray; Robert Dale Mayer; Diane Newman; Leroy Nyberg; Christopher K Payne; Ursula Wesselmann; Martha M Faraday
Journal:  J Urol       Date:  2011-04-16       Impact factor: 7.600

  7 in total
  3 in total

1.  Comparison of intravesical instillation of hyaluronic acid with intradetrusor botulinum toxin A injection or cystoscopic hydrodistention for ketamine-associated cystitis.

Authors:  Bingkun Li; Qu Leng; Chuanyin Li; Xiao Tan; Wei Su; Chaoming Li
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

Review 2.  Molecular Mechanisms and Key Processes in Interstitial, Hemorrhagic and Radiation Cystitis.

Authors:  Clément Brossard; Anne-Charlotte Lefranc; Anne-Laure Pouliet; Jean-Marc Simon; Marc Benderitter; Fabien Milliat; Alain Chapel
Journal:  Biology (Basel)       Date:  2022-06-28

3.  Peripheral antinociceptive effects of a bifunctional μ and δ opioid receptor ligand in rat model of inflammatory bladder pain.

Authors:  Maia Terashvili; Bhavana Talluri; Watchareepohn Palangmonthip; Kenneth A Iczkowski; Patrick Sanvanson; Bidyut K Medda; Banani Banerjee; Christopher W Cunningham; Jyoti N Sengupta
Journal:  Neuropharmacology       Date:  2021-07-10       Impact factor: 5.273

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.